版本:
中国

BRIEF-Synergy Pharmaceuticals announces issuance of three new patents expected to extend Trulance patent protection until 2032

April 12 Synergy Pharmaceuticals Inc

* Announces issuance of three new patents expected to extend Trulance (Plecanatide) patent protection until 2032

* United States Patent and Trademark Office (USPTO) has issued three new patents covering Trulance (Plecanatide) Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐